IGF1 and hyperinsulinism: The hallmark of the metabolic syndrome is insulin resistance, and the resultant hyperinsulinemia leads to decreased concentrations of IGF binding proteins and increased levels of bioavailable insulin-like growth factor-1 (IGF-1) [9].